Thyrocare Technologies allots 3.22 mn equity shares @ Rs. 446/share

The company has finalized the allocation of 3,223,411 equity shares at Rs. 446 per equity share (upper end of the Price Band) aggregating to Rs. 143.76 crore to 15 anchor investors

Apr 27, 2016 03:04 IST India Infoline News Service

Thyrocare Technologies Limited (the “Company” or “Issuer”) has finalized the allocation of 3,223,411 equity shares at Rs. 446 per equity share (upper end of the Price Band) aggregating to Rs. 143.76 crore to 15 anchor investors - Anchor investors include: Nomura, Merrill Lynch Capital Markets Espana, DSP Blackrock, HDFC MF, Birla Sunlife MF, Reliance Capital, SBI MF, ICICI Prudential, Tata AIA Life Insurance, Copthall Mauritius, Spring Healthcare India Trust, FIL Investments Mauritius, L&T MF, Sundaram MF & DB International Asia. Anchor investor notice for Thyrocare Technologies Limited (IPO) has been issued

The anchor investors include: The Nomura Trust And Banking Co., Ltd As The Trustee Of Nomura India Stock Mother Fund -  214,894 equity shares- 6.67%; DSP Blackrock Emerging Stars Fund - 214,894 equity shares- 6.67%; HDFC Trustee Company Ltd - HDFC Core And Satellite Fund - 214,894 equity shares -  6.67%; Birla Sunlife Trustee Company Private Limited A/C Birla Sunlife Small And Midcap Fund - 59,740 equity shares - 1.85%; Birla Sunlife Trustee Company Private Limited A/C Birla Sunlife India Gennext Fund -  77,008 equity shares - 2.39%; Birla Sunlife Trustee Company Private Limited A/C Birla Sunlife Emerging Leaders Fund Series 3 -  50,158 equity shares - 1.56%; Birla Sunlife Trustee Company Private Limited A/C Birla Sunlife Emerging Leaders Fund Series 4 - 27,988 equity shares   0.87%; Reliance Capital Trustee Co Ltd - A/C Reliance Mid & Small Cap Fund - 214,894 equity shares - 6.67%; SBI Magnum Multiplier Fund -  53,699 equity shares 1.67%; SBI Magnum Midcap Fund- 53,731 equity shares 1.67%; SBI Pharma Fund -53,731 equity shares 1.67%; SBI Long Term Advantage Fund-Series III - - 21,474 equity shares - 0.67%; SBI Magnum Children's Benefit Plan - 10,753 equity shares  0.33%; SBI Magnum Monthly Income Plan Floater - 10,753 equity shares 0.33%; SBI Resurgent India Opportunities Scheme - 10,753 equity shares - 0.33%; ICICI Prudential Business Cycle Fund Series 1 -   53,732 equity shares     1.67% ; ICICI Prudential Mutual Growth Fund - Series 8 - 21,505 equity shares  0.67%; ICICI Prudential India Recovery Fund - Series 1- 75,204 equity shares  2.33%; ICICI Prudential Value Fund  Series 6 - 64,453 equity shares 2%; Tata AIA Life Insurance Co Ltd A/C Whole Life Mid Cap Equity Fund -  214,894 equity shares - 6.67%; Merrill Lynch Capital Markets Espana S.A.S.V. -  214,895 equity shares 6.67%; Copthall Mauritius Investment Limited - 214,894 equity shares 6.67%; Spring Healthcare India Ltd – 179,452 equity shares – 5.57%; FIl Investments ( Mauritius) Ltd – 214921 equity shares – 6.67%; L&T Mutual Fund A/C L&T Midcap Fund – 112134 equity shares 3.48%; Sundaram BNP Paribas Balanced Fund – 33627 equity shares – 1.04%; Sundaram BNP Paribas MF AC Sundaram BNP Paribas Equity Multiplier Fund 33627 equity shares – 1.04%; Sundaram Mutual Fund A/C Sundaram BNP Paribas Smile Fund -44,880 equity shares – 1.39%; and DB International (Asia) Limited – 455,829 equity shares - 14.14%.

The Company will open on Wednesday, April 27, 2016, a Public Offer of up to 10,744,708 equity shares of face value of Rs. 10 each (the “Equity Shares”) for cash, at a price band of between Rs. 420 to Rs. 446 per Equity Share, (including sharepremium per Equity Share) through an offer for sale (the “Offer”) by the selling shareholders - as follows: (i) up to 10,207,472 Equity Shares offered by Agalia Private Limited; (ii) up to 180,000 Equity Shares offered by A. Sundararaju HUF; (iii) up to 180,000 Equity Shares offered by A. Velumani HUF; and; (iv) up to 177,236 Equity Shares offered by Anand Velumani.

Bids can be made for a minimum of 33 Equity Shares and in multiples of 33 Equity Shares thereafter. The Company and the Selling Shareholders may, in consultation with the Book Running Lead Managers (the “BRLMs”), consider participation by Anchor Investors in accordancewith the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended (the “SEBI Regulations”). The Anchor Investor Bid/Offer Period shall be one Working Day prior to the Bid/Offer Opening Date. The Bid/ Offer will close on Friday, April 29, 2016.

The Equity Shares offered through the Offer are proposed to be listed on National Stock Exchange of India Limited (“NSE”) and BSE Limited (“BSE”). For the Offer, NSE shall be the Designated Stock Exchange.

The BRLMs to the Offer are JM Financial Institutional Securities Limited, Edelweiss Financial Services Limited and ICICI Securities Limited.

Read More: Thyrocare Technologies IPO: Should you subscribe?

Related Story